Liposomal Bupivacaine Versus Bupivacaine for for Postoperative Pain Control in Shoulder Surgery
Status:
Recruiting
Trial end date:
2022-03-01
Target enrollment:
Participant gender:
Summary
This is a randomized, single blinded clinical trial whose purpose is to assess the impact of
liposomal bupivacaine (LB) in a single shot interscalene nerve block compared with standard
bupivacaine (same dose) in a single shot interscalene nerve block in terms of postoperative
pain control. Specifically, outpatient pain scores,use of postoperative pain medicine and
patient-reported functional outcomes after shoulder arthroplasty surgery will be evaluated.